220 related articles for article (PubMed ID: 37533233)
1. A critical assessment of the whole plant-based phytotherapeutics from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
Toxicol Mech Methods; 2023 Oct; 33(8):698-706. PubMed ID: 37533233
[No Abstract] [Full Text] [Related]
2. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
[No Abstract] [Full Text] [Related]
3. Metabolic characterization of Withania somnifera from different regions of India using NMR spectroscopy.
Namdeo AG; Sharma A; Yadav KN; Gawande R; Mahadik KR; Lopez-Gresa MP; Kim HK; Choi YH; Verpoorte R
Planta Med; 2011 Nov; 77(17):1958-64. PubMed ID: 21728148
[TBL] [Abstract][Full Text] [Related]
4. Elicitation Approaches for Withanolide Production in Hairy Root Culture of Withania somnifera (L.) Dunal.
Sivanandhan G; Selvaraj N; Ganapathi A; Manickavasagam M
Methods Mol Biol; 2016; 1405():1-18. PubMed ID: 26843160
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
[TBL] [Abstract][Full Text] [Related]
6. Distribution of withaferin A, an anticancer potential agent, in different parts of two varieties of Withania somnifera (L.) Dunal. grown in Sri Lanka.
Siriwardane AS; Dharmadasa RM; Samarasinghe K
Pak J Biol Sci; 2013 Feb; 16(3):141-4. PubMed ID: 24171276
[TBL] [Abstract][Full Text] [Related]
7. Withanolide A is inherently de novo biosynthesized in roots of the medicinal plant Ashwagandha (Withania somnifera).
Sangwan RS; Das Chaurasiya N; Lal P; Misra L; Tuli R; Sangwan NS
Physiol Plant; 2008 Jun; 133(2):278-87. PubMed ID: 18312497
[TBL] [Abstract][Full Text] [Related]
8. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
Trivedi MK; Panda P; Sethi KK; Jana S
Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
[TBL] [Abstract][Full Text] [Related]
9. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
10. Subcritical water extraction of withanosides and withanolides from ashwagandha (Withania somnifera L) and their biological activities.
Nile SH; Nile A; Gansukh E; Baskar V; Kai G
Food Chem Toxicol; 2019 Oct; 132():110659. PubMed ID: 31276745
[TBL] [Abstract][Full Text] [Related]
11. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
12. Extraction Optimization for Phenolic- and Withanolide-Rich Fractions from
Kumar S; Singh R; Gajbhiye N; Dhanani T
J AOAC Int; 2018 Nov; 101(6):1773-1780. PubMed ID: 29945694
[No Abstract] [Full Text] [Related]
13. Qualitative and quantitative variations in withanolides and expression of some pathway genes during different stages of morphogenesis in Withania somnifera Dunal.
Sabir F; Mishra S; Sangwan RS; Jadaun JS; Sangwan NS
Protoplasma; 2013 Apr; 250(2):539-49. PubMed ID: 22878597
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of withanolide biosynthesis in relation to temporal expression pattern of metabolic genes in Withania somnifera (L.) Dunal: a comparative study in two morpho-chemovariants.
Dhar N; Rana S; Bhat WW; Razdan S; Pandith SA; Khan S; Dutt P; Dhar RS; Vaishnavi S; Vishwakarma R; Lattoo SK
Mol Biol Rep; 2013 Dec; 40(12):7007-16. PubMed ID: 24190485
[TBL] [Abstract][Full Text] [Related]
15. Metabolomics of Withania somnifera (L.) Dunal: Advances and applications.
Tetali SD; Acharya S; Ankari AB; Nanakram V; Raghavendra AS
J Ethnopharmacol; 2021 Mar; 267():113469. PubMed ID: 33075439
[TBL] [Abstract][Full Text] [Related]
16. Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives.
Rai M; Jogee PS; Agarkar G; dos Santos CA
Pharm Biol; 2016; 54(2):189-97. PubMed ID: 25845640
[TBL] [Abstract][Full Text] [Related]
17. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
18. Endophytes of Withania somnifera modulate in planta content and the site of withanolide biosynthesis.
Pandey SS; Singh S; Pandey H; Srivastava M; Ray T; Soni S; Pandey A; Shanker K; Babu CSV; Banerjee S; Gupta MM; Kalra A
Sci Rep; 2018 Apr; 8(1):5450. PubMed ID: 29615668
[TBL] [Abstract][Full Text] [Related]
19. Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera.
Joshi P; Misra L; Siddique AA; Srivastava M; Kumar S; Darokar MP
Steroids; 2014 Jan; 79():19-27. PubMed ID: 24184562
[TBL] [Abstract][Full Text] [Related]
20. An updated review on phytochemistry and molecular targets of
Bashir A; Nabi M; Tabassum N; Afzal S; Ayoub M
Front Pharmacol; 2023; 14():1049334. PubMed ID: 37063285
[No Abstract] [Full Text] [Related]
[Next] [New Search]
